Complex Regional Pain Syndrome (CRPS) Market
Market Insights on Complex Regional Pain Syndrome (CRPS) covering sales outlook, demand forecast & up-to-date key trends
Complex Regional Pain Syndrome (CRPS) Market by Therapy Type, Route Of Administration, Distribution Channel & Region - Forecast 2022-2032
Complex Regional Pain syndrome (CRPS) Market Snapshot (2022-2032)
[290 Pages Report] The global market for complex regional pain syndrome (CRPS) is estimated to be worth US$ 101.9 Million in 2022, rising to US$ 126.7 Million by 2032. During the projection period of 2022-2032, the market is forecast to grow at a CAGR of 2.2%.
The increase in the number of individuals suffering from complex regional pain syndrome (CRPS), chronic pain, and failing back syndrome is one of the major reasons driving market development. Complex Regional Pain Syndrome (CRPS) is a chronic pain disorder that can affect the entire body or only the legs, arms, feet, and hands. There are two forms of CRPS, each with identical symptoms and treatments. Complex Regional Pain Syndrome (CRPS) Type I arises after an injury without any nerve damage (also known as reflex sympathetic dystrophy). Type II CRPS develops as a result of a particular nerve damage or trauma.
The prognosis of complicated regional pain syndrome varies by individual. In most situations, CRPS is minor, and the patient progressively heals over time; but, in other cases, the symptoms are severe, resulting in long-term impairment. CRPS affects both men and women equally; however women are more likely to be impacted.
The exact aetiology of Complex Regional Pain Syndrome (CRPS) is unknown. CRPS is caused by an injury or trauma in around 90% of patients. Leg immobility, soft tissue damage, fracture, sprain, or needle stick injuries produced during surgical procedures are all typical causes of injury. In individuals with CRPS, peripheral nerve abnormalities include unmyelinated and weakly myelinated nerve fibres at the axon area, which creates aberrant neurological symptoms.
|
Data Points |
Key Statistics |
|
Expected Market Value (2022) |
US$ 101.9 Million |
|
Anticipated Forecast Value (2032) |
US$ 126.7 Million |
|
Projected Growth Rate (2022-2032) |
2.2% CAGR |
Because CRPS tissue has an increased level of inflammatory molecules such as cytokines, it is frequent in people with inflammatory and autoimmune disorders. Currently, the genetic propensity to Complex Regional Pain Syndrome is not being studied extensively. A study on the family incidence of CRPS in Dutch patients discovered that CRPS may occur in a familial form, but the inheritance pattern remained unknown. The number of symptoms and the individual's medical history influence the diagnosis of CRPS. There are just a few diagnostic procedures for CRPS.
According to the incidence statistics, females are three times more impacted than males. According to a research done in the United Kingdom, one in every 3,800 persons gets CRPS each year. Therapy (Rehabilitation Therapy, Psychotherapy) or pharmaceuticals such as nonsteroidal anti-inflammatory drugs, corticosteroids, and others can be used to treat CRPS.
Let us know your requirement to get
100% FREE customization
Complex Regional Pain Syndrome (CRPS) Demand Analysis (2016 to 2021) Vs Market Outlook (2022 to 2032)
The global demand for complex regional pain syndrome (CRPS) is projected to increase at a CAGR of 2.2% during the forecast period between 2022 and 2032, reaching a total of US$ 126.7 Million in 2032, according to a report from Future Market Insights (FMI). From 2016 to 2021, sales witnessed significant growth, registering a CAGR of 1.5%.
CRPS is more frequent in women and can occur at any age, according to the National Institute of Neurological Disorders and Stroke (NINDS). Furthermore, 90% of instances were caused by trauma or injury. As a result, the growing number of people suffering from chronic pain drives market growth.
Moreover, a growth in R&D spending by both private and governmental entities, as well as favourable government legislation, are some of the key drivers projected to drive the market in the next years. The Worldwide Research Foundation for RDS/CRPS, for example, developed an international research network to help educate medical professionals and promote research.
Which are Some Prominent Drivers of Complex Regional Pain syndrome (CRPS) Market?
Growing Number of People Suffering from Chronic Pain to Boost Demand
There are currently no medications authorised by the US FDA for the treatment of Complex Regional Pain Syndrome. Physicians, on the other hand, recommended therapy and medications to treat chronic pain.
The US Food and Drug Administration recently identified Neridronic acid as a breakthrough drug in clinical studies for Complex Regional Pain Syndrome. The FDA has also granted the medicine Fast-track and orphan drug designations. Intense research and development, an increase in the number of CRPS cases, and the successful completion of clinical studies are expected to accelerate the expansion of complex regional pain syndrome market.
Moreover, the growing number of non-profit initiatives, increased R&D funding by private and public organisations, and various government initiatives to raise awareness about the syndrome are expected to drive market growth during the forecast period. For example, the U.S. Pain Foundation, a non-profit organisation, is committed to supporting persons who suffer from chronic pain disorders. The US Pain Foundation's aim is to empower, educate, and connect those suffering from severe chronic diseases.
Furthermore, rising R&D efforts and FDA approvals of new medications are likely to boost market expansion throughout the forecast period. For example, the FDA awarded orphan drug classification to Soin Therapeutics, an Ohio-based pharmaceutical firm, in September 2021 for low dosage Naltrexone (LDN) to treat Complex Regional Pain Syndrome (CRPS).
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhat are the Challenges Faced by the Complex Regional Pain syndrome (CRPS) Market?
Tight Regulatory Approval and High Medicine Costs to Hinder Market Growth
In the near future, the tight regulatory approval and high medicine costs may limit the growth of the complex regional pain syndrome market. In addition to that, dearth of in-depth knowledge of CRPS, shortage of medical and behavioural pain management professionals, and a dearth of effective treatment choices are the primary challenges impeding the growth of the complex regional pain syndrome market. Furthermore, in poorer nations, a dearth of information of the target ailment may limit market growth.
Region-Wise Insights
How Will the Complex Regional Pain syndrome (CRPS) Business Expand across North America?
Patients' Increased Awareness of Disease Remittance Therapy Creating Opportunities for Complex Regional Pain syndrome (CRPS) manufacturers
North America is at the vanguard of regional growth and a significant revenue provider on a worldwide scale. Patients' increased awareness of disease remittance therapy, the expanding frequency of CRPS, and high public and private healthcare spending are all driving the region's rise.
Moreover, simple access to high-quality healthcare, good reimbursement regulations, a robust clinical pipeline, and the approval of innovative medications are expected to drive revenue growth in North America. The increased knowledge of disease remittance therapy among patients, the rising prevalence of CRPS, and high public and private healthcare spending are driving market expansion in these areas.
Furthermore, simple access to high-quality healthcare, a robust clinical pipeline, and the approval of innovative medications are projected to boost market expansion in North America. Thus, due to the aforementioned reasons, North America is expected to possess 58.5% market share in 2022, registering a CAGR of 2.1% for Complex Regional Pain syndrome (CRPS) market in the assessment period 2022-2032.
How will Asia Pacific Create Growth Opportunities for the Complex Regional Pain syndrome (CRPS) Market?
Increasing Number of Patients fueling Rapid Adoption
Throughout the projection period, Asia Pacific is expected to be the fastest growing market. As more people live in cities, the number of patients in the region is growing. This, combined with rising healthcare spending, is likely to push the APAC market. Over the projected period, favourable regulatory rules for medication approval are expected to enhance demand for the regional market.
The key tactics followed by prominent companies in the worldwide complex regional pain syndrome (CRPS) market have been expansion in emerging countries and a higher emphasis on early diagnosis, screening, monitoring, and pharmacological clinical development. Thus, Asia Pacific is expected to procure 35% market share in 2022.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
Category-Wise Insights
Which Therapy Type is in High Demand in the Complex Regional Pain Syndrome (CRPS)?
Drug-based Therapy to Remain highly sought after
Based on therapy type, drug-based therapy accounted for a greater proportion of the complex regional pain syndrome (CRPS) market in 2020. This is mostly due to an increase in the prevalence of several forms of chronic pain, such as lower back pain, severe headache or migraine pain, and face discomfort.
Furthermore, due to the world's expanding elderly population, sedentary lifestyle, and rising number of surgical operations, the market for pain reliever medications is predicted to expand throughout the forecast period. Thus, by therapy type, drugs are expected to grow at a 2% CAGR in the Complex Regional Pain syndrome (CRPS) market in the sales indicator period 2022-2032.
Which is the Leading Distribution Channel in the Complex Regional Pain Syndrome (CRPS) Market?
The Hospital Pharmacy Category is witnessing Huge Demand in the Complex Regional Pain syndrome (CRPS) systems Market
Based on end use, the hospital pharmacy category is predicted to grow at the fastest rate in the market during the forecast period. Hospitals are the major end consumers of chronic pain treatment products, accounting for the largest market share of the market in 2020. Pain management strategies are becoming increasingly common in hospitals, particularly for post-surgical pain. As a result of the increasing number of surgical operations worldwide, hospital pharmacy is likely to continue to generate a strong demand for Complex Regional Pain syndrome (CRPS).
The most common Complex Regional Pain syndrome (CRPS) techniques are conducted in hospitals, notably for post-surgical pain, where the cost of monitoring and treating side effects creates a strong demand for Complex Regional Pain syndrome (CRPS) medications and technologies. Thus, by distribution channel, the hospital pharmacy category is expected to hold the largest market share for Complex Regional Pain syndrome (CRPS) market in the forecast period 2022-2032.
Start-Ups for Complex Regional Pain Syndrome (CRPS) Market
Key startup players in the Complex Regional Pain syndrome (CRPS) market are:
- Brazos Biomedical (TENS) Transcutaneous Electrical Nerve Stimulation: Transcutaneous electrical nerve stimulation technique stimulates muscles and nerves with small electrical pulses delivered through specific pads to relieve pain. When electricity strikes the nerve system, it disrupts pain signals travelling between the fibres and the brain. Such gadgets are compact and portable, bringing pain care to the patient's location.
Brazos Biomedical is a start-up established in the United States that provides a wearable, holocephalic medical equipment. To treat migraine discomfort, the start-up’s technology electrically stimulates the trigeminal and occipital nerves. This non-invasive therapeutic method may give alleviation for this medical problem that is underserved.
- Nalu Medical- Spinal Cord Stimulation
Before reaching the brain, the spinal cord stimulation system gathers and suppresses pain impulses. This method consists of a tiny device that, like a pacemaker, sends electrical pulses to the spinal cord. This assists patients in better managing chronic pain and reducing their reliance on opioid drugs.
Nalu Medical is a firm located in the United States that is working on an implanted medical device. It is used as an additional treatment for people suffering from persistent pain in the trunk or limbs. The company also provides an External Trial Stimulator (ETS) for use during a Spinal Cord Stimulation (SCS) trial before implanting the permanent device.
Market Competition
Mallinckrodt Pharmaceuticals, GlaxoSmithKline plc. Mylan N.V., Teva Pharmaceutical Industries Ltd., AbbVie, ACTAVIS, Zydus Pharmaceuticals, Inc., Sandoz, and Janssen Global Services, LL., are among the companies involved.
Recent Developments in the Complex Regional Pain Syndrome (CRPS) Market
- In August 2022, GSK plc announced that the New Drug Application (NDA) for momelotinib, a potential new medicine with a proposed differentiated mechanism of action that may address the significant unmet medical needs of myelofibrosis patients with anaemia, had been accepted by the US Food and Drug Administration (FDA).
- In June 2022, Mallinckrodt plc, a global biopharmaceutical company announced the resubmission of the Company's New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for the investigational agent terlipressin to treat adults with hepatorenal syndrome (HRS), an acute and life-threatening condition with no FDA-approved treatment.
Report Scope
|
Report Attribute |
Details |
|
Market Value in 2022 |
US$ 101.9 Million |
|
Market Value in 2032 |
US$ 126.7 Million |
|
Growth Rate |
CAGR of 2.1% from 2022 to 2032 |
|
Base Year for Estimation |
2021 |
|
Historical Data |
2016-2021 |
|
Forecast Period |
2022-2032 |
|
Quantitative Units |
Revenue in US$ Million and CAGR from 2022-2032 |
|
Report Coverage |
Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
|
Segments Covered |
|
|
Regions Covered |
|
|
Key Countries Profiled |
|
|
Key Companies Profiled |
|
|
Customization |
Available Upon Request |
Key Segments Profiled in the Complex Regional Pain syndrome (CRPS) Industry Survey
Complex Regional Pain Syndrome (CRPS) Market by Therapy Type:
- Physical CRPS Therapy
- CRPS Therapy via Drugs
- Analgesics
- Antidepressants
- Corticosteroids
- Others
- CRPS Therapy via Surgical Sympathectomy
- CRPS Therapy via Intrathecal Drug Pumps
- CRPS Therapy via Spinal Cord Stimulation
Complex Regional Pain Syndrome (CRPS) Market by Route of Administration:
- Oral CRPS Therapy
- Intravenous CRPS Therapy
Complex Regional Pain syndrome (CRPS) Market by Distribution Channel:
- Hospital Pharmacy
- Drug Stores
- Retail Pharmacy
- E-Commerce
Complex Regional Pain Syndrome (CRPS) Market by Region:
- North America Complex Regional Pain syndrome (CRPS) Market
- Latin America Complex Regional Pain syndrome (CRPS) Market
- Europe Complex Regional Pain syndrome (CRPS) Market
- Asia Pacific Complex Regional Pain syndrome (CRPS) Market
- Middle East and Africa Complex Regional Pain syndrome (CRPS) Market
Frequently Asked Questions
FMI projects the global Complex Regional Pain syndrome (CRPS) market to expand at a 2.2% value CAGR by 2032.
What is the estimated market value of Complex Regional Pain syndrome (CRPS) market expected in 2022?
The global Complex Regional Pain syndrome (CRPS) market is estimated at a market value of US$ 101.9 Million.
What is the estimated market value of Complex Regional Pain syndrome (CRPS) market expected in 2032?
The global Complex Regional Pain syndrome (CRPS) market is expected to garner a market value of US$ 126.7 Million.
North America is expected to possess 58.5% market share in 2022.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Complex Regional Pain Syndrome Market Analysis 2016-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) Analysis, 2016-2021
4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Complex Regional Pain Syndrome Market Analysis 2016-2021 and Forecast 2022-2032, By Therapy Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) Analysis By Therapy Type, 2016-2021
5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Therapy Type, 2022-2032
5.3.1. Physical Therapy
5.3.2. Drugs
5.3.2.1. Analgesics
5.3.2.2. Antidepressants
5.3.2.3. Corticosteroids
5.3.2.4. Other Drugs
5.3.3. Surgical Sympathectomy
5.3.4. Intrathecal Drug Pumps
5.3.5. Spinal Cord Stimulation
5.4. Y-o-Y Growth Trend Analysis By Therapy Type, 2016-2021
5.5. Absolute $ Opportunity Analysis By Therapy Type, 2022-2032
6. Global Complex Regional Pain Syndrome Market Analysis 2016-2021 and Forecast 2022-2032, By Route of Administration
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) Analysis By Route of Administration, 2016-2021
6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Route of Administration, 2022-2032
6.3.1. Oral
6.3.2. Intravenous
6.4. Y-o-Y Growth Trend Analysis By Route of Administration, 2016-2021
6.5. Absolute $ Opportunity Analysis By Route of Administration, 2022-2032
7. Global Complex Regional Pain Syndrome Market Analysis 2016-2021 and Forecast 2022-2032, By Distribution Channel
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Mn) Analysis By Distribution Channel, 2016-2021
7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2022-2032
7.3.1. Hospital Pharmacy
7.3.2. Drug Stores
7.3.3. Retail Pharmacy
7.3.4. E-commerce
7.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2016-2021
7.5. Absolute $ Opportunity Analysis By Distribution Channel, 2022-2032
8. Global Complex Regional Pain Syndrome Market Analysis 2016-2021 and Forecast 2022-2032, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2016-2021
8.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. MEA
8.4. Market Attractiveness Analysis By Region
9. North America Complex Regional Pain Syndrome Market Analysis 2016-2021 and Forecast 2022-2032, By Country
9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021
9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
9.2.1. By Country
9.2.1.1. U.S.
9.2.1.2. Canada
9.2.2. By Therapy Type
9.2.3. By Route of Administration
9.2.4. By Distribution Channel
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Therapy Type
9.3.3. By Route of Administration
9.3.4. By Distribution Channel
9.4. Key Takeaways
10. Latin America Complex Regional Pain Syndrome Market Analysis 2016-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021
10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Therapy Type
10.2.3. By Route of Administration
10.2.4. By Distribution Channel
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Therapy Type
10.3.3. By Route of Administration
10.3.4. By Distribution Channel
10.4. Key Takeaways
11. Europe Complex Regional Pain Syndrome Market Analysis 2016-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021
11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. U.K.
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Europe
11.2.2. By Therapy Type
11.2.3. By Route of Administration
11.2.4. By Distribution Channel
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Therapy Type
11.3.3. By Route of Administration
11.3.4. By Distribution Channel
11.4. Key Takeaways
12. Asia Pacific Complex Regional Pain Syndrome Market Analysis 2016-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021
12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.1.4. India
12.2.1.5. Malaysia
12.2.1.6. Singapore
12.2.1.7. Australia
12.2.1.8. New Zealand
12.2.1.9. Rest of APAC
12.2.2. By Therapy Type
12.2.3. By Route of Administration
12.2.4. By Distribution Channel
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Therapy Type
12.3.3. By Route of Administration
12.3.4. By Distribution Channel
12.4. Key Takeaways
13. MEA Complex Regional Pain Syndrome Market Analysis 2016-2021 and Forecast 2022-2032, By Country
13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021
13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
13.2.1. By Country
13.2.1.1. GCC Countries
13.2.1.2. South Africa
13.2.1.3. Israel
13.2.1.4. Rest of MEA
13.2.2. By Therapy Type
13.2.3. By Route of Administration
13.2.4. By Distribution Channel
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Therapy Type
13.3.3. By Route of Administration
13.3.4. By Distribution Channel
13.4. Key Takeaways
14. Key Countries Complex Regional Pain Syndrome Market Analysis
14.1. U.S.
14.1.1. Pricing Analysis
14.1.2. Market Share Analysis, 2021
14.1.2.1. By Therapy Type
14.1.2.2. By Route of Administration
14.1.2.3. By Distribution Channel
14.2. Canada
14.2.1. Pricing Analysis
14.2.2. Market Share Analysis, 2021
14.2.2.1. By Therapy Type
14.2.2.2. By Route of Administration
14.2.2.3. By Distribution Channel
14.3. Brazil
14.3.1. Pricing Analysis
14.3.2. Market Share Analysis, 2021
14.3.2.1. By Therapy Type
14.3.2.2. By Route of Administration
14.3.2.3. By Distribution Channel
14.4. Mexico
14.4.1. Pricing Analysis
14.4.2. Market Share Analysis, 2021
14.4.2.1. By Therapy Type
14.4.2.2. By Route of Administration
14.4.2.3. By Distribution Channel
14.5. Germany
14.5.1. Pricing Analysis
14.5.2. Market Share Analysis, 2021
14.5.2.1. By Therapy Type
14.5.2.2. By Route of Administration
14.5.2.3. By Distribution Channel
14.6. U.K.
14.6.1. Pricing Analysis
14.6.2. Market Share Analysis, 2021
14.6.2.1. By Therapy Type
14.6.2.2. By Route of Administration
14.6.2.3. By Distribution Channel
14.7. France
14.7.1. Pricing Analysis
14.7.2. Market Share Analysis, 2021
14.7.2.1. By Therapy Type
14.7.2.2. By Route of Administration
14.7.2.3. By Distribution Channel
14.8. Spain
14.8.1. Pricing Analysis
14.8.2. Market Share Analysis, 2021
14.8.2.1. By Therapy Type
14.8.2.2. By Route of Administration
14.8.2.3. By Distribution Channel
14.9. Italy
14.9.1. Pricing Analysis
14.9.2. Market Share Analysis, 2021
14.9.2.1. By Therapy Type
14.9.2.2. By Route of Administration
14.9.2.3. By Distribution Channel
14.10. China
14.10.1. Pricing Analysis
14.10.2. Market Share Analysis, 2021
14.10.2.1. By Therapy Type
14.10.2.2. By Route of Administration
14.10.2.3. By Distribution Channel
14.11. Japan
14.11.1. Pricing Analysis
14.11.2. Market Share Analysis, 2021
14.11.2.1. By Therapy Type
14.11.2.2. By Route of Administration
14.11.2.3. By Distribution Channel
14.12. South Korea
14.12.1. Pricing Analysis
14.12.2. Market Share Analysis, 2021
14.12.2.1. By Therapy Type
14.12.2.2. By Route of Administration
14.12.2.3. By Distribution Channel
14.13. Malaysia
14.13.1. Pricing Analysis
14.13.2. Market Share Analysis, 2021
14.13.2.1. By Therapy Type
14.13.2.2. By Route of Administration
14.13.2.3. By Distribution Channel
14.14. Singapore
14.14.1. Pricing Analysis
14.14.2. Market Share Analysis, 2021
14.14.2.1. By Therapy Type
14.14.2.2. By Route of Administration
14.14.2.3. By Distribution Channel
14.15. Australia
14.15.1. Pricing Analysis
14.15.2. Market Share Analysis, 2021
14.15.2.1. By Therapy Type
14.15.2.2. By Route of Administration
14.15.2.3. By Distribution Channel
14.16. New Zealand
14.16.1. Pricing Analysis
14.16.2. Market Share Analysis, 2021
14.16.2.1. By Therapy Type
14.16.2.2. By Route of Administration
14.16.2.3. By Distribution Channel
14.17. GCC Countries
14.17.1. Pricing Analysis
14.17.2. Market Share Analysis, 2021
14.17.2.1. By Therapy Type
14.17.2.2. By Route of Administration
14.17.2.3. By Distribution Channel
14.18. South Africa
14.18.1. Pricing Analysis
14.18.2. Market Share Analysis, 2021
14.18.2.1. By Therapy Type
14.18.2.2. By Route of Administration
14.18.2.3. By Distribution Channel
14.19. Israel
14.19.1. Pricing Analysis
14.19.2. Market Share Analysis, 2021
14.19.2.1. By Therapy Type
14.19.2.2. By Route of Administration
14.19.2.3. By Distribution Channel
15. Market Structure Analysis
15.1. Competition Dashboard
15.2. Competition Benchmarking
15.3. Market Share Analysis of Top Players
15.3.1. By Regional
15.3.2. By Therapy Type
15.3.3. By Route of Administration
15.3.4. By Distribution Channel
16. Competition Analysis
16.1. Competition Deep Dive
16.1.1. Mallinckrodt Pharmaceutical
16.1.1.1. Overview
16.1.1.2. Product Portfolio
16.1.1.3. Profitability by Market Segments
16.1.1.4. Sales Footprint
16.1.1.5. Strategy Overview
16.1.1.5.1. Marketing Strategy
16.1.2. GlaxoSmithKline plc.
16.1.2.1. Overview
16.1.2.2. Product Portfolio
16.1.2.3. Profitability by Market Segments
16.1.2.4. Sales Footprint
16.1.2.5. Strategy Overview
16.1.2.5.1. Marketing Strategy
16.1.3. Mylan N.V.
16.1.3.1. Overview
16.1.3.2. Product Portfolio
16.1.3.3. Profitability by Market Segments
16.1.3.4. Sales Footprint
16.1.3.5. Strategy Overview
16.1.3.5.1. Marketing Strategy
16.1.4. Teva Pharmaceutical Industries Ltd.
16.1.4.1. Overview
16.1.4.2. Product Portfolio
16.1.4.3. Profitability by Market Segments
16.1.4.4. Sales Footprint
16.1.4.5. Strategy Overview
16.1.4.5.1. Marketing Strategy
16.1.5. AbbVie
16.1.5.1. Overview
16.1.5.2. Product Portfolio
16.1.5.3. Profitability by Market Segments
16.1.5.4. Sales Footprint
16.1.5.5. Strategy Overview
16.1.5.5.1. Marketing Strategy
16.1.6. ACTAVIS
16.1.6.1. Overview
16.1.6.2. Product Portfolio
16.1.6.3. Profitability by Market Segments
16.1.6.4. Sales Footprint
16.1.6.5. Strategy Overview
16.1.6.5.1. Marketing Strategy
16.1.7. Zydus Pharmaceuticals, Inc.
16.1.7.1. Overview
16.1.7.2. Product Portfolio
16.1.7.3. Profitability by Market Segments
16.1.7.4. Sales Footprint
16.1.7.5. Strategy Overview
16.1.7.5.1. Marketing Strategy
16.1.8. Sandoz
16.1.8.1. Overview
16.1.8.2. Product Portfolio
16.1.8.3. Profitability by Market Segments
16.1.8.4. Sales Footprint
16.1.8.5. Strategy Overview
16.1.8.5.1. Marketing Strategy
16.1.9. Janssen Global Services, LLC.
16.1.9.1. Overview
16.1.9.2. Product Portfolio
16.1.9.3. Profitability by Market Segments
16.1.9.4. Sales Footprint
16.1.9.5. Strategy Overview
16.1.9.5.1. Marketing Strategy
16.1.10. MedlinePlus
16.1.10.1. Overview
16.1.10.2. Product Portfolio
16.1.10.3. Profitability by Market Segments
16.1.10.4. Sales Footprint
16.1.10.5. Strategy Overview
16.1.10.5.1. Marketing Strategy
17. Assumptions & Acronyms Used
18. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 1: Global Complex Regional Pain Syndrome Market Value (US$ Mn) Forecast by Region, 2016-2032
Table 2: Global Complex Regional Pain Syndrome Market Value (US$ Mn) Forecast by Therapy Type, 2016-2032
Table 3: Global Complex Regional Pain Syndrome Market Value (US$ Mn) Forecast by Route of Administration, 2016-2032
Table 4: Global Complex Regional Pain Syndrome Market Value (US$ Mn) Forecast by Distribution Channel, 2016-2032
Table 5: North America Complex Regional Pain Syndrome Market Value (US$ Mn) Forecast by Country, 2016-2032
Table 6: North America Complex Regional Pain Syndrome Market Value (US$ Mn) Forecast by Therapy Type, 2016-2032
Table 7: North America Complex Regional Pain Syndrome Market Value (US$ Mn) Forecast by Route of Administration, 2016-2032
Table 8: North America Complex Regional Pain Syndrome Market Value (US$ Mn) Forecast by Distribution Channel, 2016-2032
Table 9: Latin America Complex Regional Pain Syndrome Market Value (US$ Mn) Forecast by Country, 2016-2032
Table 10: Latin America Complex Regional Pain Syndrome Market Value (US$ Mn) Forecast by Therapy Type, 2016-2032
Table 11: Latin America Complex Regional Pain Syndrome Market Value (US$ Mn) Forecast by Route of Administration, 2016-2032
Table 12: Latin America Complex Regional Pain Syndrome Market Value (US$ Mn) Forecast by Distribution Channel, 2016-2032
Table 13: Europe Complex Regional Pain Syndrome Market Value (US$ Mn) Forecast by Country, 2016-2032
Table 14: Europe Complex Regional Pain Syndrome Market Value (US$ Mn) Forecast by Therapy Type, 2016-2032
Table 15: Europe Complex Regional Pain Syndrome Market Value (US$ Mn) Forecast by Route of Administration, 2016-2032
Table 16: Europe Complex Regional Pain Syndrome Market Value (US$ Mn) Forecast by Distribution Channel, 2016-2032
Table 17: Asia Pacific Complex Regional Pain Syndrome Market Value (US$ Mn) Forecast by Country, 2016-2032
Table 18: Asia Pacific Complex Regional Pain Syndrome Market Value (US$ Mn) Forecast by Therapy Type, 2016-2032
Table 19: Asia Pacific Complex Regional Pain Syndrome Market Value (US$ Mn) Forecast by Route of Administration, 2016-2032
Table 20: Asia Pacific Complex Regional Pain Syndrome Market Value (US$ Mn) Forecast by Distribution Channel, 2016-2032
Table 21: MEA Complex Regional Pain Syndrome Market Value (US$ Mn) Forecast by Country, 2016-2032
Table 22: MEA Complex Regional Pain Syndrome Market Value (US$ Mn) Forecast by Therapy Type, 2016-2032
Table 23: MEA Complex Regional Pain Syndrome Market Value (US$ Mn) Forecast by Route of Administration, 2016-2032
Table 24: MEA Complex Regional Pain Syndrome Market Value (US$ Mn) Forecast by Distribution Channel, 2016-2032
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 1: Global Complex Regional Pain Syndrome Market Value (US$ Mn) by Therapy Type, 2022-2032
Figure 2: Global Complex Regional Pain Syndrome Market Value (US$ Mn) by Route of Administration, 2022-2032
Figure 3: Global Complex Regional Pain Syndrome Market Value (US$ Mn) by Distribution Channel, 2022-2032
Figure 4: Global Complex Regional Pain Syndrome Market Value (US$ Mn) by Region, 2022-2032
Figure 5: Global Complex Regional Pain Syndrome Market Value (US$ Mn) Analysis by Region, 2016-2032
Figure 6: Global Complex Regional Pain Syndrome Market Value Share (%) and BPS Analysis by Region, 2022-2032
Figure 7: Global Complex Regional Pain Syndrome Market Y-o-Y Growth (%) Projections by Region, 2022-2032
Figure 8: Global Complex Regional Pain Syndrome Market Value (US$ Mn) Analysis by Therapy Type, 2016-2032
Figure 9: Global Complex Regional Pain Syndrome Market Value Share (%) and BPS Analysis by Therapy Type, 2022-2032
Figure 10: Global Complex Regional Pain Syndrome Market Y-o-Y Growth (%) Projections by Therapy Type, 2022-2032
Figure 11: Global Complex Regional Pain Syndrome Market Value (US$ Mn) Analysis by Route of Administration, 2016-2032
Figure 12: Global Complex Regional Pain Syndrome Market Value Share (%) and BPS Analysis by Route of Administration, 2022-2032
Figure 13: Global Complex Regional Pain Syndrome Market Y-o-Y Growth (%) Projections by Route of Administration, 2022-2032
Figure 14: Global Complex Regional Pain Syndrome Market Value (US$ Mn) Analysis by Distribution Channel, 2016-2032
Figure 15: Global Complex Regional Pain Syndrome Market Value Share (%) and BPS Analysis by Distribution Channel, 2022-2032
Figure 16: Global Complex Regional Pain Syndrome Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022-2032
Figure 17: Global Complex Regional Pain Syndrome Market Attractiveness by Therapy Type, 2022-2032
Figure 18: Global Complex Regional Pain Syndrome Market Attractiveness by Route of Administration, 2022-2032
Figure 19: Global Complex Regional Pain Syndrome Market Attractiveness by Distribution Channel, 2022-2032
Figure 20: Global Complex Regional Pain Syndrome Market Attractiveness by Region, 2022-2032
Figure 21: North America Complex Regional Pain Syndrome Market Value (US$ Mn) by Therapy Type, 2022-2032
Figure 22: North America Complex Regional Pain Syndrome Market Value (US$ Mn) by Route of Administration, 2022-2032
Figure 23: North America Complex Regional Pain Syndrome Market Value (US$ Mn) by Distribution Channel, 2022-2032
Figure 24: North America Complex Regional Pain Syndrome Market Value (US$ Mn) by Country, 2022-2032
Figure 25: North America Complex Regional Pain Syndrome Market Value (US$ Mn) Analysis by Country, 2016-2032
Figure 26: North America Complex Regional Pain Syndrome Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 27: North America Complex Regional Pain Syndrome Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 28: North America Complex Regional Pain Syndrome Market Value (US$ Mn) Analysis by Therapy Type, 2016-2032
Figure 29: North America Complex Regional Pain Syndrome Market Value Share (%) and BPS Analysis by Therapy Type, 2022-2032
Figure 30: North America Complex Regional Pain Syndrome Market Y-o-Y Growth (%) Projections by Therapy Type, 2022-2032
Figure 31: North America Complex Regional Pain Syndrome Market Value (US$ Mn) Analysis by Route of Administration, 2016-2032
Figure 32: North America Complex Regional Pain Syndrome Market Value Share (%) and BPS Analysis by Route of Administration, 2022-2032
Figure 33: North America Complex Regional Pain Syndrome Market Y-o-Y Growth (%) Projections by Route of Administration, 2022-2032
Figure 34: North America Complex Regional Pain Syndrome Market Value (US$ Mn) Analysis by Distribution Channel, 2016-2032
Figure 35: North America Complex Regional Pain Syndrome Market Value Share (%) and BPS Analysis by Distribution Channel, 2022-2032
Figure 36: North America Complex Regional Pain Syndrome Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022-2032
Figure 37: North America Complex Regional Pain Syndrome Market Attractiveness by Therapy Type, 2022-2032
Figure 38: North America Complex Regional Pain Syndrome Market Attractiveness by Route of Administration, 2022-2032
Figure 39: North America Complex Regional Pain Syndrome Market Attractiveness by Distribution Channel, 2022-2032
Figure 40: North America Complex Regional Pain Syndrome Market Attractiveness by Country, 2022-2032
Figure 41: Latin America Complex Regional Pain Syndrome Market Value (US$ Mn) by Therapy Type, 2022-2032
Figure 42: Latin America Complex Regional Pain Syndrome Market Value (US$ Mn) by Route of Administration, 2022-2032
Figure 43: Latin America Complex Regional Pain Syndrome Market Value (US$ Mn) by Distribution Channel, 2022-2032
Figure 44: Latin America Complex Regional Pain Syndrome Market Value (US$ Mn) by Country, 2022-2032
Figure 45: Latin America Complex Regional Pain Syndrome Market Value (US$ Mn) Analysis by Country, 2016-2032
Figure 46: Latin America Complex Regional Pain Syndrome Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 47: Latin America Complex Regional Pain Syndrome Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 48: Latin America Complex Regional Pain Syndrome Market Value (US$ Mn) Analysis by Therapy Type, 2016-2032
Figure 49: Latin America Complex Regional Pain Syndrome Market Value Share (%) and BPS Analysis by Therapy Type, 2022-2032
Figure 50: Latin America Complex Regional Pain Syndrome Market Y-o-Y Growth (%) Projections by Therapy Type, 2022-2032
Figure 51: Latin America Complex Regional Pain Syndrome Market Value (US$ Mn) Analysis by Route of Administration, 2016-2032
Figure 52: Latin America Complex Regional Pain Syndrome Market Value Share (%) and BPS Analysis by Route of Administration, 2022-2032
Figure 53: Latin America Complex Regional Pain Syndrome Market Y-o-Y Growth (%) Projections by Route of Administration, 2022-2032
Figure 54: Latin America Complex Regional Pain Syndrome Market Value (US$ Mn) Analysis by Distribution Channel, 2016-2032
Figure 55: Latin America Complex Regional Pain Syndrome Market Value Share (%) and BPS Analysis by Distribution Channel, 2022-2032
Figure 56: Latin America Complex Regional Pain Syndrome Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022-2032
Figure 57: Latin America Complex Regional Pain Syndrome Market Attractiveness by Therapy Type, 2022-2032
Figure 58: Latin America Complex Regional Pain Syndrome Market Attractiveness by Route of Administration, 2022-2032
Figure 59: Latin America Complex Regional Pain Syndrome Market Attractiveness by Distribution Channel, 2022-2032
Figure 60: Latin America Complex Regional Pain Syndrome Market Attractiveness by Country, 2022-2032
Figure 61: Europe Complex Regional Pain Syndrome Market Value (US$ Mn) by Therapy Type, 2022-2032
Figure 62: Europe Complex Regional Pain Syndrome Market Value (US$ Mn) by Route of Administration, 2022-2032
Figure 63: Europe Complex Regional Pain Syndrome Market Value (US$ Mn) by Distribution Channel, 2022-2032
Figure 64: Europe Complex Regional Pain Syndrome Market Value (US$ Mn) by Country, 2022-2032
Figure 65: Europe Complex Regional Pain Syndrome Market Value (US$ Mn) Analysis by Country, 2016-2032
Figure 66: Europe Complex Regional Pain Syndrome Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 67: Europe Complex Regional Pain Syndrome Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 68: Europe Complex Regional Pain Syndrome Market Value (US$ Mn) Analysis by Therapy Type, 2016-2032
Figure 69: Europe Complex Regional Pain Syndrome Market Value Share (%) and BPS Analysis by Therapy Type, 2022-2032
Figure 70: Europe Complex Regional Pain Syndrome Market Y-o-Y Growth (%) Projections by Therapy Type, 2022-2032
Figure 71: Europe Complex Regional Pain Syndrome Market Value (US$ Mn) Analysis by Route of Administration, 2016-2032
Figure 72: Europe Complex Regional Pain Syndrome Market Value Share (%) and BPS Analysis by Route of Administration, 2022-2032
Figure 73: Europe Complex Regional Pain Syndrome Market Y-o-Y Growth (%) Projections by Route of Administration, 2022-2032
Figure 74: Europe Complex Regional Pain Syndrome Market Value (US$ Mn) Analysis by Distribution Channel, 2016-2032
Figure 75: Europe Complex Regional Pain Syndrome Market Value Share (%) and BPS Analysis by Distribution Channel, 2022-2032
Figure 76: Europe Complex Regional Pain Syndrome Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022-2032
Figure 77: Europe Complex Regional Pain Syndrome Market Attractiveness by Therapy Type, 2022-2032
Figure 78: Europe Complex Regional Pain Syndrome Market Attractiveness by Route of Administration, 2022-2032
Figure 79: Europe Complex Regional Pain Syndrome Market Attractiveness by Distribution Channel, 2022-2032
Figure 80: Europe Complex Regional Pain Syndrome Market Attractiveness by Country, 2022-2032
Figure 81: Asia Pacific Complex Regional Pain Syndrome Market Value (US$ Mn) by Therapy Type, 2022-2032
Figure 82: Asia Pacific Complex Regional Pain Syndrome Market Value (US$ Mn) by Route of Administration, 2022-2032
Figure 83: Asia Pacific Complex Regional Pain Syndrome Market Value (US$ Mn) by Distribution Channel, 2022-2032
Figure 84: Asia Pacific Complex Regional Pain Syndrome Market Value (US$ Mn) by Country, 2022-2032
Figure 85: Asia Pacific Complex Regional Pain Syndrome Market Value (US$ Mn) Analysis by Country, 2016-2032
Figure 86: Asia Pacific Complex Regional Pain Syndrome Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 87: Asia Pacific Complex Regional Pain Syndrome Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 88: Asia Pacific Complex Regional Pain Syndrome Market Value (US$ Mn) Analysis by Therapy Type, 2016-2032
Figure 89: Asia Pacific Complex Regional Pain Syndrome Market Value Share (%) and BPS Analysis by Therapy Type, 2022-2032
Figure 90: Asia Pacific Complex Regional Pain Syndrome Market Y-o-Y Growth (%) Projections by Therapy Type, 2022-2032
Figure 91: Asia Pacific Complex Regional Pain Syndrome Market Value (US$ Mn) Analysis by Route of Administration, 2016-2032
Figure 92: Asia Pacific Complex Regional Pain Syndrome Market Value Share (%) and BPS Analysis by Route of Administration, 2022-2032
Figure 93: Asia Pacific Complex Regional Pain Syndrome Market Y-o-Y Growth (%) Projections by Route of Administration, 2022-2032
Figure 94: Asia Pacific Complex Regional Pain Syndrome Market Value (US$ Mn) Analysis by Distribution Channel, 2016-2032
Figure 95: Asia Pacific Complex Regional Pain Syndrome Market Value Share (%) and BPS Analysis by Distribution Channel, 2022-2032
Figure 96: Asia Pacific Complex Regional Pain Syndrome Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022-2032
Figure 97: Asia Pacific Complex Regional Pain Syndrome Market Attractiveness by Therapy Type, 2022-2032
Figure 98: Asia Pacific Complex Regional Pain Syndrome Market Attractiveness by Route of Administration, 2022-2032
Figure 99: Asia Pacific Complex Regional Pain Syndrome Market Attractiveness by Distribution Channel, 2022-2032
Figure 100: Asia Pacific Complex Regional Pain Syndrome Market Attractiveness by Country, 2022-2032
Figure 101: MEA Complex Regional Pain Syndrome Market Value (US$ Mn) by Therapy Type, 2022-2032
Figure 102: MEA Complex Regional Pain Syndrome Market Value (US$ Mn) by Route of Administration, 2022-2032
Figure 103: MEA Complex Regional Pain Syndrome Market Value (US$ Mn) by Distribution Channel, 2022-2032
Figure 104: MEA Complex Regional Pain Syndrome Market Value (US$ Mn) by Country, 2022-2032
Figure 105: MEA Complex Regional Pain Syndrome Market Value (US$ Mn) Analysis by Country, 2016-2032
Figure 106: MEA Complex Regional Pain Syndrome Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 107: MEA Complex Regional Pain Syndrome Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 108: MEA Complex Regional Pain Syndrome Market Value (US$ Mn) Analysis by Therapy Type, 2016-2032
Figure 109: MEA Complex Regional Pain Syndrome Market Value Share (%) and BPS Analysis by Therapy Type, 2022-2032
Figure 110: MEA Complex Regional Pain Syndrome Market Y-o-Y Growth (%) Projections by Therapy Type, 2022-2032
Figure 111: MEA Complex Regional Pain Syndrome Market Value (US$ Mn) Analysis by Route of Administration, 2016-2032
Figure 112: MEA Complex Regional Pain Syndrome Market Value Share (%) and BPS Analysis by Route of Administration, 2022-2032
Figure 113: MEA Complex Regional Pain Syndrome Market Y-o-Y Growth (%) Projections by Route of Administration, 2022-2032
Figure 114: MEA Complex Regional Pain Syndrome Market Value (US$ Mn) Analysis by Distribution Channel, 2016-2032
Figure 115: MEA Complex Regional Pain Syndrome Market Value Share (%) and BPS Analysis by Distribution Channel, 2022-2032
Figure 116: MEA Complex Regional Pain Syndrome Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022-2032
Figure 117: MEA Complex Regional Pain Syndrome Market Attractiveness by Therapy Type, 2022-2032
Figure 118: MEA Complex Regional Pain Syndrome Market Attractiveness by Route of Administration, 2022-2032
Figure 119: MEA Complex Regional Pain Syndrome Market Attractiveness by Distribution Channel, 2022-2032
Figure 120: MEA Complex Regional Pain Syndrome Market Attractiveness by Country, 2022-2032
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
